DUBLIN–(BUSINESS WIRE)–The “Surgical Sealants, Adhesives and Hemostats Global Market – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
SAH global market is expected to grow at mid-single digit CAGR from 2022 to 2029 to reach $4,366.0 million by 2029
The SAH global market is mainly segmented based on products, applications, end-users, and based on geography. The product market is segmented into sealant, adhesive and hemostat.
Among these, the hemostat accounted for the largest revenue in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029. The sealants are further segmented based on their origin into natural and synthetic sealants. The synthetic sealant accounted for the largest revenue in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029.
The natural sealants are further sub-segmented based on composition into fibrin and albumin sealants. Among them, fibrin accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029. The synthetic sealants are further segmented based on composition into cyanoacrylate, hydrogels, and others.
Among them, hydrogels accounted for the largest revenue in 2022 and are expected to grow at mid-single digit CAGR from 2022 to 2029. The adhesive market is segmented into natural and synthetic adhesives, among them; synthetic adhesives accounted for the largest revenue in 2022 and are expected to grow at low-single digit CAGR from 2022 to 2029.
The natural adhesives are further sub-segmented based on composition into fibrin and albumin, among them, fibrin adhesive accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029. The synthetic adhesives are further segmented based on composition into cyanoacrylate and polyurethane. The cyanoacrylate adhesive accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029.
Hemostats are classified based on function into mechanical hemostats, active hemostats, flowable hemostats, and fibrin sealants hemostats, among them, the mechanical hemostats accounted for the largest revenue in 2022 and are expected to grow at mid-single digit CAGR from 2022 to 2029. Fibrin sealant hemostat is the fastest growing segment at high-single digit strong CAGR from 2022 to 2029 because it is unique, powerful and effective for localized and diffused bleeding during surgical procedures.
The application market is segmented into Cardiovascular surgery, General Surgery, Orthopedic surgery, Urology, Pulmonology, Neurosurgery, Gynecology, Cosmetic surgery and Others. The general surgery segment accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029, because of high demand for various surgical procedures. Cosmetic surgery is the fastest growing segment at high-single digit CAGR, because of the advancements in treatment regimes available and better cosmetic outcomes.
The end-users market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment accounted for the largest share in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029, due to an increase in the aging population, increase in surgical procedural volumes, and better patient care services with advanced facilities.
Factors Influencing Market
Drivers and Opportunities
Increasing Demand for Surgical Procedures Boosts Sah Market Growth
the Emergence of Technically Advanced Products
Increasing Geriatric Population
Acquisition to Open An Array of Opportunities for the Market to Flourish
Acceptance of Sah and Market Expansion in Emerging Nations
Restraints and Threats
Pitfalls in the Usage of Sah
Expensive Sah Impeding Effective Penetration in Low and Middle-Income Countries
Unfavorable Reimbursement Policies in Developing Nations
Stringent Regulatory Guidelines
Availability of Alternative Products
Major Companies
Advanced Medical Solutions
Artivion
Baxter International, Inc
B.Braun Melsungen AG
Becton, Dickinson and Company (C.R.Bard Inc.)
Corza Medical
Integra Lifescience
Johnson & Johnson (Ethicon)
Medtronic, plc
Teleflex
Regulatory Affairs
International Organization for Standardization
Iso 9001: 2015 Quality Management System
Iso 14644-1 Cleanroom Standards
Iso 13485 Medical Devices
Iso 10993 Biological Evaluation of Medical Devices
Astm International Standards
U.S.
Canada
Europe
Japan
China
India
Technological Advancements
Bioglue
Bioinspired Glue from Barnacles
Snake-Derived Super Glue
Alga Mimetic Technology
a Polymer Patch for the Abdominal Cavity
Clinical Trials
Scope of the Market
Surgical Sealants, Adhesives and Hemostats Global Market, Based on Product
Sealants
Natural Sealants
Fibrin Natural Sealants
Albumin Natural Sealants
Synthetic Sealants
Cyanoacrylate
Hydrogels
Others
Adhesives
Natural Adhesives
Fibrin Natural Adhesives
Albumin Natural Adhesives
Synthetic Adhesives
Cyanoacrylate
Polyurethane
Hemostats
Mechanical Hemostats
Active Hemostats
Flowable Hemostats
Fibrin Sealant Hemostats
Surgical Sealants, Adhesives and Hemostats Global Market, Based on Application
Cardiovascular Surgery
General Surgery
Orthopedic Surgery
Urology
Pulmonology
Neurosurgery
Gynecology
Cosmetic Surgery
Others
Surgical Sealants, Adhesives and Hemostats Global Market, Based on End-Users
Hospitals
Ambulatory Surgical Centers
Others
Companies Mentioned
Adhezion Biomedical, LLC
Advanced Medical Solutions Group plc (Selantis)
Aegis-Lifesciences
Artivion (Cryolife)
Axio Bioscience
B.Braun Melsungen AG
Baxter International, Inc.
Becton Dickinson and Company (Tissumed)
Beaver Visitec International
Betatech Medical
Biocer Entwicklungs-Gmbh
Biom’Up
Boz Medical
Chemence Medical, Inc.
Corza Medical
CSL Behring
Dalim Tissen
Dsi Ltd
Equimedical
Gatt Tech
Gelita Medical
Gem Srl
Glustitich, Inc.
Green Cross Biopharma
Grena
Grunenthal GmbH (Adhesys Medical Gmbh)
H.B. Fuller
Hager & Werken GmbH & Co. Kg
Haulan Bioengineering Co Ltd
Healthium
Hemarus Therapeutics
Hemostatis
Ibc Pharmaceuticals, Ltd.
Integra Lifesciences Holding Corporation
Johnson & Johnson (Ethicon)
Katsan Medical Devices
Medtronic
Meril Life Sciences Pvt. Ltd
Ocular Therapeutix, Inc.
Optmed, Inc.
Peter Surgical
Pfizer
Reliance Lifescience
Samyang Holdings Corporation
Shanghai Raas
Starsil Hemostat
Stryker
Symatese
Teleflex
Terumo Corporation
Theracion Biomedical
Tissium (Gecko Medical)
Tricol Biomedical
Vivostat A/S
Wortham Laboratories Inc
Zhejiang Perfectseal
For more information about this report visit https://www.researchandmarkets.com/r/u7svcu
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
